PIEZO-卵胞浆内单精子注射与传统卵胞浆内单精子注射相比改善受精率、退化率和胚胎质量:一项同胞卵母细胞分半多中心试验
这项同胞卵母细胞分半多中心试验纳入108例不孕女性,将成熟卵母细胞分半分别行PIEZO-ICSI与传统ICSI。PIEZO-ICSI组受精率71.6%显著高于传统ICSI组65.6%,卵母细胞退化率6.3%低于12.1%,第5天A、B级囊胚数33.3%高于27.5%;两组非整倍体率、利用率、临床妊娠及单胚胎移植后活产无显著差异。
要点
- PIEZO-ICSI组受精率71.6%,显著高于传统ICSI组65.6%。
- PIEZO-ICSI组卵母细胞退化率6.3%,低于传统ICSI组12.1%。
- 两组非整倍体率、利用率、临床妊娠及活产无显著差异。
核心结论
- 该试验支持PIEZO-ICSI较传统ICSI可能提高受精率、降低卵母细胞退化率并提高囊胚质量,但似乎不影响每移植周期的临床妊娠率或活产率。
研究设计与样本
- 同胞卵母细胞分半多中心试验,在不孕女性中比较PIEZO-ICSI与传统ICSI,共108例患者接受同胞卵母细胞分半使用。
- 纳入标准为诊断为不孕、采用ICSI作为授精方法且有至少6枚成熟卵母细胞可供注射的女性。
- 成熟卵母细胞队列被分半,一半行传统ICSI,另一半行PIEZO-ICSI;卵母细胞数为奇数时,多余一枚行传统ICSI;首先使用的注射技术经随机化以消除注射顺序偏倚。
主要发现
- PIEZO-ICSI组受精率为71.6%,显著高于传统ICSI组的65.6%。
- PIEZO-ICSI组卵母细胞退化率为6.3%,低于传统ICSI组的12.1%。
- 第5天发育的A级和B级囊胚数量在PIEZO-ICSI组为33.3%,高于传统ICSI组的27.5%。
- 两种注射技术之间,非整倍体率、利用率、临床妊娠或单胚胎移植后活产结局均无显著差异。
关键数值与推荐
- 主要结局指标为注射后受精率。
- PIEZO-ICSI组受精率71.6%,传统ICSI组65.6%。
- PIEZO-ICSI组卵母细胞退化率6.3%,传统ICSI组12.1%。
- 第5天A级和B级囊胚数量PIEZO-ICSI组33.3%,传统ICSI组27.5%。
临床怎么用
- 原文结论指出该试验支持PIEZO-ICSI可能提高受精率、降低卵母细胞退化率并提高囊胚质量,但似乎不影响每移植周期的临床妊娠率或活产率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate whether PIEZO-intracytoplasmic sperm injection (PIEZO-ICSI) increases the fertilization rate, decreases the degeneration rate, and increases the utilization rate per oocyte injected compared with conventional intracytoplasmic sperm injection (ICSI). DESIGN: Sibling oocyte split multicenter trial. SETTING: Fertility clinics. PATIENTS: Women with a diagnosis of infertility who used ICSI as their method of insemination and had ≥6 mature oocytes for injection. INTERVENTIONS: Participants had their mature oocyte cohort divided, where half were injected using conventional ICSI and the other half were injected using PIEZO-ICSI. For patients with an uneven oocyte number, the extra oocyte was injected using conventional ICSI. The injection technique used first was also randomized to ensure that there was no bias due to order of injection. MAIN OUTCOME MEASURE: The primary outcome measure was the fertilization rate after injection. RESULTS: A total of 108 patients underwent a sibling split use of conventional ICSI and PIEZO-ICSI. The fertilization rate was 71.6% in PIEZO-ICSI, which significantly increased compared with that in conventional ICSI 65.6%. In addition, the oocyte degeneration rate decreased in PIEZO-ICSI compared with that in conventional ICSI (6.3% vs. 12.1% respectively), and the blastocyst quality increased, as measured by the number of grade A and B quality blastocysts present on day 5 of development (33.3% vs. 27.5%). No significant differences in the aneuploidy or utilization rate, clinical pregnancy, or live birth outcome after single embryo transfer were noted between the two injection techniques. CONCLUSIONS: This trial supports the possibility that PIEZO-ICSI increases the fertilization rates, decreases the oocyte degeneration rates, and increases the blastocyst quality compared with conventional ICSI; however, it does not appear to influence the clinical pregnancy or live birth rate per transfer. CLINICIAN TRIAL REGISTRATION NUMBER: Australian and New Zealand Clinical Trial Registry ACTRN12620000407998.
引用
- Zander-Fox D, Green M, Watson K, et al. Improved fertilization, degeneration, and embryo quality rates with PIEZO-intracytoplasmic sperm injection compared with conventional intracytoplasmic sperm injection: a sibling oocyte split multicenter trial. Fertil Steril. 2024. PMID: 38272382. doi:10.1016/j.fertnstert.2024.01.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。